Lung AI vs CardIQ Suite

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Lung AI

by Exo

CardIQ Suite

by GE HealthCare

AI Verdict

Tool A, Lung AI, is a handheld ultrasound platform with AI for real-time cardiac and lung scanning, suitable for point-of-care diagnostics. Tool B, CardIQ Suite, is a CT post-processing application focused on automated calcium scoring and CCTA review for detailed cardiovascular disease diagnosis. While both leverage AI in cardiology imaging, they utilize different modalities and serve distinct clinical workflows.

Choose Lung AI if…

Choose Lung AI if you require a portable, real-time imaging solution for immediate diagnostic insights at the point of care. This tool is ideal for emergency medicine or pulmonology settings where rapid assessment of lung conditions like pleural effusion or consolidation, and initial cardiac evaluations, are critical for timely patient management. Its on-device AI processing and guided image capture streamline workflows without needing internet connectivity.

View Lung AI →

Choose CardIQ Suite if…

Choose CardIQ Suite if your workflow involves comprehensive post-processing of cardiac CT scans for detailed cardiovascular disease diagnosis and treatment planning. This solution is best suited for radiology and cardiology departments that need automated calcium scoring, in-depth CCTA review, and precise plaque burden quantification. Its integration with GE Advantage Workstations enhances efficiency for complex cardiac CT data analysis.

View CardIQ Suite →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Lung AI	CardIQ Suite
Pricing	Contact for pricing	Unknown
Deployment	On-device (integrated with Exo Iris handheld ultrasound device)	On-premise (integrated with CT systems)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool A (Lung AI) is designed as a handheld ultrasound platform with on-device AI processing, emphasizing ease of use and portability for point-of-care applications. Its features like guided image capture and integrated training (Exo U) further enhance user experience and accessibility, making it highly usable in diverse clinical settings.

Clinical Value

Tie

Both tools offer significant clinical value within their respective domains. Tool A provides real-time AI-powered detection for lung and cardiac conditions at the point of care, enabling immediate clinical decisions. Tool B offers comprehensive, automated post-processing of cardiac CT data for detailed diagnosis and treatment planning of cardiovascular disease. Given their distinct but equally critical roles in patient care, neither can be definitively declared superior in overall clinical value.

Pricing & Value

Tie

Both tools require direct contact for pricing information, leading to a lack of transparency regarding their costs. While Tool A's description mentions 'affordable' imaging, this claim cannot be substantiated without specific pricing details for either product. Therefore, it is impossible to determine a winner in terms of pricing and value.

Enterprise Readiness

CardIQ Suite

Both tools demonstrate strong enterprise readiness with HIPAA compliance, BAA agreements, and FDA clearance. Tool B, being deployed on GE's established Advantage Workstation, likely integrates seamlessly into existing radiology workflows within large healthcare systems. This established integration within a major vendor's ecosystem provides a slight edge for enterprise deployment.

Innovation

Lung AI

Tool A showcases higher innovation by integrating high-performance, real-time AI directly into a handheld ultrasound device, enabling on-device processing without internet connectivity. This approach, combined with AI-powered education, represents a more disruptive advancement in point-of-care diagnostics. Tool B, while leveraging deep learning for advanced CT post-processing, primarily enhances existing diagnostic workflows rather than introducing a new paradigm.

Support & Docs

Lung AI

Tool A explicitly highlights 'Exo U (AI-powered POCUS education and training)' as a key feature, indicating a direct investment in user support and knowledge transfer. Tool B's provided information does not include any details regarding user support, documentation, or training resources. Therefore, Tool A has a clear advantage in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Lung AI	CardIQ Suite
Company	Exo	GE Medical Systems SCS
Core AI Application	Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning	AI-powered cardiac CT post-processing for comprehensive cardiovascular disease diagnosis and treatment planning
Lung-Specific AI Features	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis	Not specified
Cardiac-Specific AI Features	Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy), Pulsed-wave Doppler capabilities (on Exo Iris)	Deep Learning based automated Calcium Score and labeling of coronary artery territories, CCTA 2D Review with cine capability, Plaque ID tool for visualizing and quantifying plaque burden
Internet Requirement for AI Processing	On-device AI processing (operates without internet)	Not specified

Videos

Demos, reviews, and walkthroughs featuring Lung AI and CardIQ Suite.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do Lung AI and CardIQ Suite integrate into a physician's existing clinical workflow, considering their distinct modalities and applications?

Lung AI by Exo is designed for real-time, point-of-care decisions with a handheld ultrasound device, fitting into immediate diagnostic workflows in specialties like emergency medicine or pulmonology. CardIQ Suite by GE Medical Systems SCS is a post-processing application for cardiac CT scans, integrating into radiology and cardiology workflows for comprehensive review and planning after image acquisition.

For which specific clinical scenarios and patient populations are Lung AI and CardIQ Suite best suited, given their different imaging modalities?

Lung AI is ideal for rapid assessment of cardiac and lung conditions at the point of care, such as detecting pleural effusion or consolidation in emergency or critical care settings. CardIQ Suite is tailored for detailed analysis of cardiac CT data, assisting cardiologists and radiologists in diagnosing and planning treatment for cardiovascular diseases through automated calcium scoring and CCTA review.

What is the expected accuracy and sensitivity of the AI algorithms for their respective diagnostic applications in Lung AI and CardIQ Suite?

Lung AI offers high accuracy, with studies showing sensitivity of 0.967 and specificity of 0.912 for pleural effusion detection, and sensitivity of 0.968 and specificity of 0.945 for consolidation/atelectasis. CardIQ Suite's deep learning models demonstrate >95% correct identification of coronary artery calcifications and >90% consistency with CACS-DRS classification grouping.

What is the anticipated learning curve for physicians to become proficient with each tool, and how quickly can they expect to realize clinical value?

Lung AI includes Exo U, an AI-powered POCUS education and training platform, which aims to reduce the learning curve for handheld ultrasound, with AI assistance enhancing clinician detection, particularly benefiting less experienced users. CardIQ Suite is built for automation and workflow efficiency in CT post-processing, with its automated calcium scoring algorithm providing results within seconds of loading, suggesting rapid integration into existing review processes.

What level of integration can be expected with existing Electronic Health Record (EHR) systems for each tool, beyond basic data transfer?

The provided information does not detail specific EHR integration capabilities for Lung AI. CardIQ Suite is part of GE HealthCare's 'AW Family' Advanced Visualization applications, with efforts towards seamless integration with enterprise imaging diagnostic applications for radiology to enhance clinical efficiency and streamline cardiology care pathways.

For a healthcare system with multiple facilities, what are the key considerations for implementing and managing each tool across different sites?

Lung AI operates on-device without internet, offering portability and ease of deployment across various sites without extensive network infrastructure. CardIQ Suite, deployed on-premise with GE Advantage Workstation, would require centralized planning for workstation availability and data management across multiple facilities.